Banff 07 classification of renal allograft pathology: updates and future directions (scientific article)

cites work (P2860)

Q33784875	"Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA - a mechanism involved in SERPINE1 (PAI-1) overexpression".
Q91850724	2013 Banff Criteria for Acute Antibody-Mediated Rejection Are Superior to 2007 Banff Criteria in the Diagnosis and Assessment of Renal Allograft Outcomes
Q86421417	7th International Immunoglobulin Conference: Transplantation
Q37780676	A 'biomarker signature' for tolerance in transplantation
Q57175415	A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology
Q42846833	A Critical Appraisal of Methods to Grade Transplant Glomerulitis in Renal Allograft Biopsies
Q49916963	A Novel Model of Mouse-to-Rat Kidney Xenotransplantation.
Q48186622	A Probabilistic Approach to Histologic Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Biopsies
Q42849503	A Systematic Method for Categorizing GN.
Q36063312	A case of desensitization, transplantation, and allograft dysfunction
Q51559236	A chronic renal rejection model with a fully MHC-mismatched rat strain combination under immunosuppressive therapy.
Q35008036	A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation
Q33793057	A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipients
Q47850607	A molecular biopsy test based on arteriolar under-hyalinosis reflects increased probability of rejection related to under-immunosuppression
Q39869686	A molecular classifier for predicting future graft loss in late kidney transplant biopsies
Q51432032	A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants.
Q92522477	A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation
Q35755961	A rapid noninvasive assay for the detection of renal transplant injury
Q37391509	A single-centre comparison of the clinical outcomes at 6 months of renal transplant recipients administered Adoport® or Prograf® preparations of tacrolimus
Q54290180	A stringent preemptive protocol reduces cytomegalovirus disease in the first 6 months after kidney transplantation.
Q54373564	A study of the impact of cytokine gene polymorphism in acute rejection of renal transplant recipients.
Q38211716	A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection
Q92311964	A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring
Q54343045	ADAM17 up-regulation in renal transplant dysfunction and non-transplant-related renal fibrosis.
Q85964497	AKT2 is essential to maintain podocyte viability and function during chronic kidney disease
Q89303010	Abdominal Aortic Calcification in Living Kidney Donors
Q41897316	Aberrant Blood Vessel Formation Connecting the Glomerular Capillary Tuft and the Interstitium Is a Characteristic Feature of Focal Segmental Glomerulosclerosis-like IgA Nephropathy
Q38839087	Absence of Intragraft B Cells in Rejection Biopsies After Rituximab Induction Therapy: Consequences for Clinical Outcome
Q90003518	Accelerated podocyte detachment early after kidney transplantation is related to long-term allograft loss of function
Q38000780	Accompanying renal injuries did not impact graft survival in patients with transplant glomerulopathy.
Q41946081	Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis
Q41358191	Acute Rejection in Renal Transplant Patients of a Hospital in Bogota, Colombia
Q83774038	Acute antibody-mediated rejection in paediatric renal transplant recipients
Q42280145	Acute antibody-mediated rejection in pediatric kidney transplants: a single center experience
Q95380223	Acute antibody-mediated rejection of renal transplant associated with cellular crescents: first case report
Q39720454	Acute antibody-mediated renal allograft rejection associated with HLA-Cw17 antibody.
Q82270520	Acute cellular rejection in a renal allograft immediately following leukocyte engraftment after auto-SCT
Q42224060	Acute enteritis associated with Coxsackievirus A19 in a kidney transplant patient.
Q35534266	Acute graft-versus-host disease of the kidney in allogeneic rat bone marrow transplantation
Q50995169	Acute kidney injury as defined by the RIFLE criteria is a risk factor for kidney transplant graft failure.
Q43194453	Acute rejection features in dual kidney transplant recipients from elderly donors: comparison of calcineurin inhibitor-based and calcineurin inhibitor-free immunosuppressive protocols.
Q36002505	Adaptive immunity rather than viral cytopathology mediates polyomavirus-associated nephropathy in mice.
Q37676032	Advances in diagnosing and managing antibody-mediated rejection
Q38544529	Advances in pharmacotherapy to treat kidney transplant rejection
Q34862535	Advances of genomic science and systems biology in renal transplantation: a review
Q35776408	Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years
Q38186157	Alemtuzumab and minimization immunotherapy in kidney transplantation: long-term results of comparison with rabbit anti-thymocyte globulin and standard triple maintenance therapy.
Q39513891	Alemtuzumab as Antirejection Therapy: T Cell Repopulation and Cytokine Responsiveness
Q40217347	Alemtuzumab dose adjusted for body weight is associated with earlier lymphocyte repletion and less infective episodes in the first year post renal transplantation - a retrospective study.
Q86254890	Alemtuzumab induction and antibody-mediated rejection in kidney transplantation
Q36818003	Alemtuzumab induction in pediatric kidney transplantation.
Q54687845	Alemtuzumab induction with tacrolimus monotherapy in 25 pediatric renal transplant recipients.
Q52728730	Allogeneic dendritic cells stimulated with antibodies against HLA class II polarize naive T cells in a follicular helper phenotype.
Q61455909	Alteration of urinary neutrophil gelatinase-associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation
Q53667379	Alternatively activated macrophages in the pathogenesis of chronic kidney allograft injury.
Q92671945	An integrated iterative annotation technique for easing neural network training in medical image analysis
Q92068085	An intronic polymorphism of NFATC1 gene shows a risk association with biopsy-proven acute rejection in renal transplant recipients
Q40200912	An mTOR-inhibitor-based protocol and calcineurin inhibitor (CNI)-free treatment in kidney transplant recipients from donors after cardiac death: good renal function, but high incidence of conversion to CNI.
Q91883172	Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A
Q38398029	Analysis of FOXP3 gene and protein expressions in renal allograft biopsies and their association with graft outcomes.
Q47986958	Analysis of different staining techniques for c4d detection in renal allograft biopsies
Q34420715	Analysis of the differentially expressed low molecular weight peptides in human serum via an N-terminal isotope labeling technique combining nano-liquid chromatography/matrix-assisted laser desorption/ionization mass spectrometry
Q60603232	Analysis of the peripheral T-cell repertoire in kidney transplant patients
Q82213207	Anti-Angiotensin Type 1 Receptor Antibodies Associated With Antibody Mediated Rejection in Donor HLA Antibody Negative Patients
Q37354812	Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes
Q53245556	Anti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejection in patients without preformed HLA-donor-specific antibody.
Q39033553	Antibody-Mediated Acute Vascular Rejection of Kidney Allografts: Fifteen-Year Follow-up.
Q36243057	Antibody-Mediated Lung Transplant Rejection
Q38427447	Antibody-mediated rejection despite inhibition of terminal complement.
Q43257282	Antibody-mediated rejection following transplantation from an HLA-identical sibling
Q35915453	Antibody-mediated rejection in kidney transplantation: a review
Q38206175	Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options
Q38392458	Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management
Q91251184	Antibody-mediated rejection in the Banff classifications of 2007 and 2017: A comparison of renal graft loss prediction capability
Q52401610	Antibody-mediated rejection: New approaches in prevention and management.
Q42553965	Antibody-mediated rejection: pathogenesis, prevention, treatment, and outcomes
Q86421437	Antibody-mediated vascular rejection of kidney allograft: characterization of different kidney allograft rejection phenotypes via histology, C4d deposition and donor-specific antibodies
Q38062614	Antibody-mediated vascular rejection of kidney allografts: a population-based study
Q34595998	Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury
Q50946412	Antithymocyte globulin induction and rapid steroid taper leads to excellent results in kidney transplantation with donation after cardiac death donors: importance of rejection and delayed graft function.
Q93063048	Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal Function
Q38683990	Application of Ultrasound Elastography for Chronic Allograft Dysfunction in Kidney Transplantation.
Q37257354	Application of systems biology principles to protein biomarker discovery: urinary exosomal proteome in renal transplantation
Q92369328	Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival
Q53482976	Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
Q47111152	Arteriovenous fistulae after renal biopsy: diagnosis and outcomes using Doppler ultrasound assessment
Q33804303	Assessment of Circulating Protein Signatures for Kidney Transplantation in Pediatric Recipients
Q33415013	Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease
Q37832966	Assessment of kidney organ quality and prediction of outcome at time of transplantation
Q53113917	Assessment of renal allograft fibrosis by transient elastography.
Q61945633	Association between IVS3 +17T/C CD28 gene polymorphism and the acute kidney allograft rejection
Q38478746	Association between interleukin-3 gene polymorphism and acute rejection after kidney transplantation
Q58803566	Association between post-transplant uric acid level and renal allograft fibrosis: Analysis using Banff pathologic scores from renal biopsies
Q92008032	Association of Intrapatient Variability of Tacrolimus Concentration With Early Deterioration of Chronic Histologic Lesions in Kidney Transplantation
Q40633497	Association of MYH9 rs3752462 and rs5756168 Polymorphisms With Transplanted Kidney Artery Stenosis.
Q45132751	Association of high anti-donor alloreactivity and low frequency of FoxP3-expressing cells prior to kidney transplantation with acute graft rejection.
Q46095776	Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy.
Q47094450	Associations between HVEM/LIGHT/BTLA/CD160 polymorphisms and the occurrence of antibody-mediate rejection in renal transplant recipients
Q53408830	Augmentation of Transient Donor Cell Chimerism and Alloantigen-Specific Regulation of Lung Transplants in Miniature Swine.
Q93562475	Authors' reply
Q55449985	B Cell Activating Factor, Renal Allograft Antibody-Mediated Rejection, and Long-Term Outcome.
Q42234521	BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION.
Q36786398	BK virus nephropathy is not always alone
Q44025547	BK virus-associated nephropathy: neutrophil gelatinase-associated lipocalin as a new diagnostic tool?
Q50127924	Balancing competing needs in kidney transplantation: does an allocation system prioritizing children affect the renal transplant function?
Q38510972	Banff 2013 update: Pearls and pitfalls in transplant renal pathology
Q53045068	Banff Histopathological Consensus Criteria for Preimplantation Kidney Biopsies.
Q44180277	Banff initiative for quality assurance in transplantation (BIFQUIT): reproducibility of C4d immunohistochemistry in kidney allografts
Q48350293	Baseline donor chronic renal injury confers the same transplant survival disadvantage for DCD and DBD kidneys.
Q46633572	Beneficial Immune Effects of Myeloid-Related Proteins in Kidney Transplant Rejection.
Q44924669	Beneficial effects of tonsillectomy for mesangial immunoglobulin A (IgA) deposition and clinical outcome in five kidney transplant patients with recurrent IgA nephropathy: case report.
Q38282840	Better understanding of transplant glomerulopathy secondary to chronic antibody-mediated rejection
Q33480997	Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood
Q38180358	Biomarkers for kidney transplant rejection
Q36285580	Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review.
Q43061612	Biomarkers in renal transplantation.
Q41035928	Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study
Q48124340	Blood capillary rarefaction and lymphatic capillary neoangiogenesis are key contributors to renal allograft fibrosis in an ACE inhibition rat model.
Q37636475	Borderline rejection after renal transplantation--to treat or not to treat
Q84556573	C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts
Q83828722	C4d deposition and multilayering of peritubular capillary basement membrane in posttransplantation membranous nephropathy indicate its association with antibody-mediated injury
Q53546683	C4d deposition is associated with immune cells infiltrating in kidney allograft glomerulitis and peritubular capillaritis.
Q37042154	C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts
Q34335372	C4d immunohistochemistry in membranous nephropathy
Q38430795	C4d immunoreactivity of intraoperative zero-hour biopsy in renal allograft
Q41944673	C4d staining in allograft biopsies
Q85035529	C4d staining in post-reperfusion renal biopsy is not useful for the early detection of antibody-mediated rejection when CDC crossmatching is negative
Q34927206	C4d staining in renal allograft biopsies with early acute rejection and subsequent clinical outcome
Q42943616	C4d-Positive Renal Allograft Rejection Biopsies in Cyclosporine-Treated Patients: Single-Center Incidence and Outcome
Q46092609	C4d/CD34 double-immunofluorescence staining of renal allograft biopsies for assessing peritubular capillary C4d positivity.
Q36003085	CC Chemokine Ligand 18 in ANCA-Associated Crescentic GN.
Q40919282	CD154-CD40 T-cell co-stimulation pathway is a key mechanism in kidney ischemia-reperfusion injury
Q35993141	CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis.
Q36037639	CD28 family and chronic rejection: "to belatacept...And beyond!".
Q38116657	Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence
Q53702610	Calcineurin inhibitors and nephrotoxicity in children.
Q35016679	Capability of utilizing CYP3A5 polymorphisms to predict therapeutic dosage of tacrolimus at early stage post-renal transplantation
Q45971335	Cell-Free DNA and Active Rejection in Kidney Allografts.
Q30301338	Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus
Q35192003	Challenges inherent to the diagnosis of antibody-mediated rejection in lung transplantation
Q85903639	Changes in glomerular filtration rate after donation in living kidney donors: a single-center cohort study
Q53229165	Characterisation of Tertiary Lymphoid Organs in Explanted Rejected Donor Kidneys.
Q51087941	Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Q33908781	Characterization of acute renal allograft rejection by proteomic analysis of renal tissue in rat.
Q64097475	Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing
Q53215066	Chimeric Allografts Induced by Short-Term Treatment With Stem Cell Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: II, Study in Miniature Swine.
Q26775103	Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug Targets
Q36445529	Chronic allograft injury by subclinical borderline change: evidence from serial protocol biopsies in kidney transplantation
Q44276263	Chronic histological damage in early indication biopsies is an independent risk factor for late renal allograft failure.
Q49796927	Circulating and urinary microRNAs as possible biomarkers in kidney transplantation
Q90428801	Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients
Q94661248	Clinical Characteristic and Outcomes of BK Virus Infection in Kidney Transplant Recipients Managed Using a Systematic Surveillance and Treatment Strategy
Q36822826	Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.
Q47313617	Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients
Q92670695	Clinical Significance of Renal Allograft Protocol Biopsies: A Single Tertiary Center Experience in Malaysia
Q104802057	Clinical and Pathologic Feature of Patients With Early Versus Late Active Antibody-Mediated Rejection After Kidney Transplantation: A Single-Center Experience
Q47574733	Clinical and histopathologic features of antibody-mediated rejection among pediatric renal transplant recipients with preformed vs de novo donor-specific antibodies
Q39015291	Clinical and immunological relevance of antibodies in solid organ transplantation
Q50802039	Clinical and molecular significance of microvascular inflammation in transplant kidney biopsies.
Q40882057	Clinical and pathological analyses of chronic vascular rejection after kidney transplantation
Q45146264	Clinical and pathological analyses of transplant glomerulopathy cases
Q33412327	Clinical aspects: focusing on key unique organ-specific issues of renal transplantation
Q53536007	Clinical assessment of lipid profiles in live kidney donors.
Q85216717	Clinical correlation of nitric oxide levels with acute rejection in renal transplantation
Q40441830	Clinical effects of pre-transplant serum 25-hydroxyvitamin D level on post-transplant immunologic and non-immunologic outcomes in kidney transplant recipients
Q100426458	Clinical outcome of living donor kidney transplantation across simultaneous ABO and HLA incompatibility: Single center experience of first ten cases
Q39571464	Clinical outcome of norovirus infection in renal transplant patients
Q40217293	Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: a nationwide cohort study.
Q39452807	Clinical outcomes with ABO antibody titer variability in a multicenter study of ABO-incompatible kidney transplantation in the United Kingdom
Q84289061	Clinical relevance of sHLA-G-mediated with better graft acceptance in early posttransplantation
Q37974480	Clinical role of the renal transplant biopsy
Q55401748	Clinical significance of CCR7+CD8+ T cells in kidney transplant recipients with allograft rejection.
Q90242167	Clinical significance of CD161+CD4+ T cells in the development of chronic antibody-mediated rejection in kidney transplant recipients
Q88907649	Clinical significance of Th17 cells in kidney transplantation
Q43628579	Clinical significance of isolated v lesions in paediatric renal transplant biopsies: muscular arteries required to refute the diagnosis of acute rejection
Q38409644	Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction
Q50969140	Clinicopathologic analysis of acute vascular rejection cases after renal transplantation.
Q42748427	Collapsing glomerulopathy in renal allograft biopsies: A study of nine cases
Q37367683	Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure.
Q83327057	Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China
Q45221842	Combined analysis of cytokine gene polymorphism and the level of expression with allograft function in kidney transplant recipients
Q87441668	Comparative analysis of inflammatory infiltrates in collagen-induced arthritis, kidney graft rejection and delayed-type hypersensitivity in non-human primates
Q39716270	Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection.
Q50177690	Comparison of Rejection-Specific Genes in Peripheral Blood and Allograft Biopsy From Kidney Transplant.
Q48658882	Comparison of Ultrasound Corticomedullary Strain with Doppler Parameters in Assessment of Renal Allograft Interstitial Fibrosis/Tubular Atrophy
Q83725168	Comparison of basiliximab and daclizumab with triple immunosuppression in renal transplantation
Q38476939	Comparison of clinical outcome between high and low baseline anti-ABO antibody titers in ABO-incompatible kidney transplantation
Q57053812	Comparison of native and transplant kidney biopsies: diagnostic yield and complications
Q41107159	Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2-year prospective study
Q90734448	Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi/ARB on the histology and function of renal allografts
Q53261586	Compartment-specific expression of natural killer cell markers in renal transplantation: immune profile in acute rejection.
Q33648605	Compartmental localization and clinical relevance of MICA antibodies after renal transplantation
Q33419693	Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy
Q39371134	Complement in Kidney Transplantation
Q46970385	Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment
Q36926228	Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up
Q90292344	Complications and clinical management of ultrasound-guided renal allograft biopsies
Q38861411	Concurrent Post-Transplantation Diabetes Mellitus in Renal Allograft Recipients With Immunoglobulin A Nephropathy.
Q41701385	Contrast-enhanced ultrasonography in the early period after kidney transplantation predicts long-term allograft function.
Q51744862	Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor-specific antibodies.
Q43808149	Conversion to sirolimus in pediatric renal transplant patients: a single-center experience
Q47396102	Correlation Between Renal Cortical Stiffness and Histological Determinants by Point Shear-Wave Elastography in Patients With Kidney Transplantation.
Q89029577	Correlation Between the Transplant Evaluation Rating Scale (TERS) and Medical Outcomes in Living-Donor Kidney Transplant Recipients: A Retrospective Analysis
Q40549258	Correlation between ICAM1 and VCAM1 gene polymorphisms and histopathological changes in kidney allograft biopsies
Q53108115	Correlation of acute tubular injury in reperfusion biopsy with renal transplant outcomes.
Q44279733	Correlations with six-month protocol biopsy findings in pediatric transplant recipients on low- and regular-dose CNI regimens
Q79815538	Cross Reactive Epitope Group antibodies in sensitized kidneys transplant recipients was associated with early acute Antibody Mediated Rejection
Q38795065	Current pathological perspectives on chronic rejection in renal allografts
Q38843499	Current status of pediatric renal transplant pathology
Q38510977	Currently available useful immunohistochemical markers of renal pathology for the diagnosis of renal allograft rejection
Q50711738	Cyclodextrin curcumin formulation improves outcome in a preclinical pig model of marginal kidney transplantation.
Q42250541	Cytomegalovirus infection in renal transplant recipients: one center's experience
Q37778827	Cytomegalovirus-associated renal allograft rejection: new challenges for antiviral preventive strategies
Q34427661	Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions
Q53320581	DNA double-strand breaks induced intractable glomerular fibrosis in renal allografts.
Q50548088	DRβ11501, DQβ10602 donor allelic haplotype and humoral antibody episodes of acute renal allograft rejection.
Q40468571	De novo donor-specific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability.
Q39837936	De novoTherapy with Everolimus, Low‐Dose Ciclosporine A, Basiliximab and Steroid Elimination in Pediatric Kidney Transplantation
Q47211243	Death with graft function after kidney transplantation: a single-center experience
Q84203120	Decrease of blood type antigenicity over the long-term after ABO-incompatible kidney transplantation
Q55334450	Decreased expression of sirtuin 3 protein correlates with early stage chronic renal allograft dysfunction in a rat kidney model.
Q39615715	Decreased humoral antibody episodes of acute renal allograft rejection in recipients expressing the HLA-DQβ1*0202 allele
Q34560989	Defining nephrotic syndrome from an integrative genomics perspective
Q34106643	Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival
Q101131723	Delayed non-myeloablative irradiation to induce long-term allograft acceptance in a large animal lung transplantation model
Q30681903	Dendritic Cells in Kidney Transplant Biopsy Samples Are Associated with T Cell Infiltration and Poor Allograft Survival
Q35940388	Depression of Complement Regulatory Factors in Rat and Human Renal Grafts Is Associated with the Progress of Acute T-Cell Mediated Rejection.
Q35995043	Derivation and validation of a cytokine-based assay to screen for acute rejection in renal transplant recipients
Q36566858	Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation
Q38601238	Design and Methods of the Korean Organ Transplantation Registry
Q37685073	Detecting adaptive immunity: applications in transplantation monitoring
Q38001495	Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe?
Q54309295	Detection on dynamic changes of endothelial cell specific molecule-1 in acute rejection after renal transplantation.
Q38460398	Determination of rituximab dose according to immunologic risk in ABO-incompatible kidney transplantation
Q61946036	Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant
Q46253453	Diagnosis and follow-up of chronic kidney graft dysfunction: from DFG to new biomarkers
Q46045914	Diagnosis and treatment of acute humoral kidney allograft rejection.
Q50700853	Diagnosis of early pancreas graft failure via antibody-mediated rejection: single-center experience with 256 pancreas transplantations.
Q90268718	Diagnosis of renal transplant rejection: Banff classification and beyond
Q43116382	Diagnostic significance of peritubular capillary basement membrane multilaminations in kidney allografts: old concepts revisited
Q40815282	Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations
Q54225470	Differences in Proinflammatory Cytokines and Monocyte Subtypes in Older as Compared With Younger Kidney Transplant Recipients.
Q46887236	Different regulatory and cytotoxic CD4+ T lymphocyte profiles in renal transplants with antibody-mediated chronic rejection or long-term good graft function.
Q41721696	Differential expression of microRNAs in renal transplant patients with acute T-cell mediated rejection
Q33530073	Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats
Q64088359	Differential microRNA Profile in Operational Tolerance: A Potential Role in Favoring Cell Survival
Q53206118	Diffusion-Weighted imaging and diffusion tensor imaging detect delayed graft function and correlate with allograft fibrosis in patients early after kidney transplantation.
Q34775333	Digital pathology evaluation of complement C4d component deposition in the kidney allograft biopsies is a useful tool to improve reproducibility of the scoring
Q34839515	Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy
Q36040154	Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis
Q87491593	Do the abnormal results of an implantation renal biopsy affect the donor renal function?
Q37226086	Does African American Race Impact Statin Efficacy in Renal Transplant Outcomes?
Q96639257	Donor Klotho KL-VS Polymorphism Predicts Allograft Glomerulosclerosis and Early Post-Transplant Kidney Function
Q48185108	Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients.
Q33561691	Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts
Q35568602	Donor caveolin 1 (CAV1) genetic polymorphism influences graft function after renal transplantation.
Q42111937	Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.
Q33871973	Dynamic Changes of IFN-γ-producing Cells, TGF-β and Their Preidctive Value in Early Outcomees of Renal Transplantation
Q34979223	Dynamic change of glomerular filtration rate in the early stage is associated with kidney allograft status: a preliminary report
Q40219212	EMMPRIN expression is involved in the development of interstitial fibrosis and tubular atrophy in human kidney allografts
Q36949149	Early Posttransplant Isolated v1 Lesion Does Not Need to Be Treated and Does Not Lead to Increased Fibrosis
Q47385592	Early Sirolimus Conversion as Rescue Therapy in Kidneys With Prolonged Delayed Graft Function in Deceased Donor Renal Transplant
Q50229155	Early Steroid Withdrawal in Recipients of a Kidney Transplant From a Living Donor: Experience of a Single Mexican Center.
Q34805695	Early acceptance of renal allografts in mice is dependent on foxp3(+) cells.
Q40791125	Early cytomegalovirus-specific T-cell response and estimated glomerular filtration rate identify patients at high risk of infection after renal transplantation.
Q36029152	Early loss of peritubular capillaries after kidney transplantation.
Q44601996	Early steroid withdrawal compared with steroid avoidance correlates with graft failure among kidney transplant recipients with an history of diabetes
Q33849715	Ectopic B-cell clusters that infiltrate transplanted human kidneys are clonal
Q33408360	Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes
Q33425079	Eculizumab in Transplant-Associated Thrombotic Microangiopathy.
Q39176690	Effect of ABO incompatibility on T-cell flow cytometry cross-match results prior to living donor kidney transplantation.
Q57489314	Effect of Early Immunosuppression Therapy on De Novo Anti-Human-Leukocyte-Antigen Antibody After Kidney Transplantation
Q40176022	Effect of Immigration Status on Outcomes in Pediatric Kidney Transplant Recipients
Q34114659	Effect of donor and recipient variables on the long-term live-donor renal allograft survival in children.
Q38980502	Effect of intraoperative transesophageal Doppler-guided fluid therapy versus central venous pressure-guided fluid therapy on renal allograft outcome in patients undergoing living donor renal transplant surgery: a comparative study
Q33879559	Effect of mycophenolate mofetil on progression of interstitial fibrosis and tubular atrophy after kidney transplantation: a retrospective study
Q51731677	Effect of polyethylene glycol-based preservation solutions on graft injury in experimental kidney transplantation.
Q27027082	Effector mechanisms of rejection
Q30252315	Effects of DNA Methylation on Progression to Interstitial Fibrosis and Tubular Atrophy in Renal Allograft Biopsies: A Multi-omics Approach
Q37230389	Effects of Lung Cotransplantation on Cardiac Allograft Tolerance Across a Full Major Histocompatibility Complex Barrier in Miniature Swine
Q51121337	Effects of alloantibodies to human leukocyte antigen on endothelial expression and serum levels of thrombomodulin.
Q35788609	Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients
Q89909507	Efficacy of anti-T-lymphocyte globulin-Fresenius as an induction agent in deceased-donor renal transplantation: A cohort study
Q50998040	Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results.
Q86047158	Electron microscopy contribution to diagnosing transplant glomerulopathy: a single-center experience
Q85570107	Electron microscopy in determining the etiology of kidney allograft dysfunction
Q37708699	Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease
Q37960177	Emerging drugs for the treatment of transplant rejection
Q61796690	Endocan as a marker of microvascular inflammation in kidney transplant recipients
Q54983740	Endothelial Dysfunction in Kidney Transplantation.
Q40806353	Endothelial activation, lymphangiogenesis, and humoral rejection of kidney transplants
Q35550551	Endothelial cell antibodies associated with novel targets and increased rejection
Q92346707	Epidemiology and Pathophysiology of Glomerular C4d Staining in Native Kidney Biopsies
Q44061780	Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study
Q34817706	Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside?
Q47248357	Etiology and renal outcomes of acute tubulointerstitial nephritis: a single-center prospective cohort study in China
Q41076574	Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients
Q30405394	Evaluation of molecular profiles in calcineurin inhibitor toxicity post-kidney transplant: input to chronic allograft dysfunction
Q43219632	Evaluation of renal allograft function early after transplantation with diffusion-weighted MR imaging
Q36482167	Evaluation of vascular lesions using circulating endothelial cells in renal transplant patients
Q36069536	Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques.
Q53378324	Evolution of Renal Function in Renal Allograft Recipients Under Various Everolimus-Based Immunosuppressive Regimens.
Q53633264	Evolution of allograft fibrosis and function in kidney transplant recipients: a retrospective analysis of stable patients under CNI and mTORi.
Q52562157	Evolution of renal function and urinary biomarker indicators of inflammation on serial kidney biopsies in pediatric kidney transplant recipients with and without rejection.
Q36400872	Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center
Q44696405	Excess fluid distribution affects tacrolimus absorption in peritoneal dialysis patients.
Q40513558	Experience with belatacept rescue therapy in kidney transplant recipients.
Q35021857	Experimental glomerular endothelial injury in vivo
Q44738359	Exposure to mycophenolic acid better predicts immunosuppressive efficacy than exposure to calcineurin inhibitors in renal transplant patients.
Q49923255	Expression and significance of Sirt1 in renal allografts at the early stage of chronic renal allograft dysfunction
Q41985015	Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype.
Q35866243	Expression of GSK-3β in renal allograft tissue and its significance in pathogenesis of chronic allograft dysfunction
Q50973137	Expression of HLA-G transcripts in graft biopsy samples of renal transplant recipients.
Q36517411	Expression of MMP-2 and TIMP-1 in renal tissue of patients with chronic active antibody-mediated renal graft rejection
Q53510694	Expression of bone morphogenetic proteins 4, 6 and 7 is downregulated in kidney allografts with interstitial fibrosis and tubular atrophy.
Q47965283	Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae-Related Urinary Tract Infection in Kidney Transplant Recipients: Risk Factors, Treatment, and Long-Term Outcome.
Q43281190	FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis
Q40092236	Factors Contributing to the Success of Ultrasound-Guided Native Renal Biopsy.
Q53765280	Fas/Fas Ligand pathways gene polymorphisms in pediatric renal allograft rejection.
Q50255957	FcγRIIa defunctioning polymorphism in paediatric patients with renal allograft.
Q34445181	Feto-placental adaptations to maternal obesity in the baboon
Q47386658	Fibrin thrombi in deceased donor kidneys: Prevalence and influence on graft function and graft survival in transplanted patients.
Q48109478	Ficolin-2 Gene rs7851696 Polymorphism is Associated with Delayed Graft Function and Acute Rejection in Kidney Allograft Recipients.
Q44394620	First clinical experience with polysol solution: pilot study in living kidney transplantation
Q45351621	Five-year outcomes in living donor kidney transplants with a positive crossmatch.
Q43037651	Focal C4d staining in peritubular capillaries and kidney graft survival: results of a retrospective study
Q37315152	Focal C4d+ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival
Q53522519	Functional MRI detects perfusion impairment in renal allografts with delayed graft function.
Q35653607	Functional and histological improvement after everolimus rescue of chronic allograft dysfunction in renal transplant recipients
Q36979317	Ganciclovir prophylaxis improves late murine cytomegalovirus-induced renal allograft damage
Q37918402	Gene expression profiling in organ transplantation
Q33890390	Genetic polymorphisms of Interleukin-18 are not associated with allograft function in kidney transplant recipients
Q47898148	Genetics of acute rejection after kidney transplantation.
Q37560649	Genome-Wide Association Study of Acute Renal Graft Rejection
Q38781656	German recommendations for pretransplantation donor kidney biopsies
Q58004250	Glomerular C4d Immunoreactivity in Acute Rejection Biopsies of Renal Transplant Patients
Q36800330	Glomerular and tubular C4d depositions in IgA nephropathy: relations with histopathology and with albuminuria
Q33392769	Glomerular fibrin thrombi in ABO and crossmatch compatible renal allograft biopsies
Q38476290	Graft volume as the surrogate marker for nephron number affects the outcomes of living-donor kidney transplantation
Q89472835	HLA in transplantation
Q55488653	HLA-DQA1, -DQB1, and -DRB1 Alleles Associated with Acute Tubulointerstitial Nephritis in a Chinese Population: A Single-Center Cohort Study.
Q42214078	HLA-DRB1 and susceptibility to kidney allograft rejection in Southern Iranian patients.
Q33424902	Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
Q41217282	High Intrapatient Variability of Tacrolimus Levels and Outpatient Clinic Nonattendance Are Associated With Inferior Outcomes in Renal Transplant Patients
Q92134658	High neutrophil to lymphocyte ratio predicts acute allograft rejection in kidney transplantation; a retrospective study
Q38967641	Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study
Q38148703	Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification
Q38154130	Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation
Q35791488	Hospital Admission following Acute Kidney Injury in Kidney Transplant Recipients Is Associated with a Negative Impact on Graft Function after 1-Year
Q48206489	Hyalinosis Lesions in Renal Transplant Biopsies: Time-Dependent Complexity of Interpretation
Q48245968	Hypothermic pulsatile preservation of kidneys from uncontrolled deceased donors after cardiac arrest - a retrospective study.
Q36040523	IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease
Q48347925	IL-6 production by monocytes is associated with graft function decline in patients with borderline changes suspicious for acute T-cell-mediated rejection: a pilot study.
Q47761551	Identification of the effects of aging-related gene-matrix metalloproteinase on allograft outcomes in kidney transplantation
Q52890132	Identifying Subphenotypes of Antibody-Mediated Rejection in Kidney Transplants.
Q35049801	Identifying biomarkers as diagnostic tools in kidney transplantation
Q36417907	IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury
Q91620438	Immunoenzymatic Staining of Caveolin-1 in Formalin-Fixed Renal Graft Showing Chronic Antibody Mediated Rejection
Q45356490	Immunohistochemical features of BK virus nephropathy in renal transplant recipients
Q53657042	Immunohistological analysis for immunological response and mechanism of interstitial fibrosis in IgG4-related kidney disease.
Q37811391	Immunologic aspects and rejection in solid organ versus reconstructive transplantation
Q46253448	Immunosuppressive strategies and chronic graft dysfunction in kidney transplantation
Q35511754	Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA.
Q36316568	Impact of ABO incompatible kidney transplantation on living donor transplantation
Q93379918	Impact of Donor Age on Clinical Outcomes of Primary Single Kidney Transplantation From Maastricht Category-III Donors After Circulatory Death
Q91301296	Impact of Subclinical Rejection on Kidney Graft Function
Q42740954	Impact of acute rejection on kidney allograft outcomes in recipients on rapid steroid withdrawal
Q37378725	Impact of combined acute rejection on BK virus-associated nephropathy in kidney transplantation
Q49297064	Impact of complement component 3/4/5 single nucleotide polymorphisms on renal transplant recipients with antibody-mediated rejection
Q38144106	Impact of donor-specific antibodies in reconstructive transplantation
Q37660263	Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy
Q53584517	Impact of metabolic syndrome on postdonation renal function in living kidney donors.
Q43492328	Impact of posttransplantation glomerulonephritis on long-term outcome of kidney transplants: single-center 20-year experience.
Q30372284	Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients.
Q51699103	Impact of the Banff 2013 classification on the diagnosis of suspicious versus conclusive late antibody-mediated rejection in allografts without acute dysfunction.
Q44987081	Impact of the pre-transplant histological score on 3-year graft outcomes of kidneys from marginal donors: a single-centre study
Q36126901	Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients
Q40567804	Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial
Q61799145	Incidence, risk factors, and outcome of BK polyomavirus infection after kidney transplantation
Q38036246	Incompatible kidney transplantation: a brief overview of the past, present and future.
Q46351643	Increase in proteinuria after acute kidney graft rejection is associated with decreased graft function and survival
Q35881771	Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
Q54481297	Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience.
Q38843990	Increased Frequency of BK Virus-Specific Polyfunctional CD8+ T Cells Predict Successful Control of BK Viremia After Kidney Transplantation
Q89138281	Increased T cell immunosenescence and accelerated maturation phenotypes in older kidney transplant recipients
Q34612770	Increased circulating miR-21 levels are associated with kidney fibrosis.
Q84820129	Increased influx of myeloid dendritic cells during acute rejection is associated with interstitial fibrosis and tubular atrophy and predicts poor outcome
Q53060554	Increased intragraft rejection-associated gene transcripts in patients with donor-specific antibodies and normal biopsies.
Q33860126	Increased migration of antigen presenting cells to newly-formed lymphatic vessels in transplanted kidneys by glycol-split heparin
Q41496012	Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis
Q64964956	Indoleamine 2,3-dioxygenase suppresses humoral alloimmunity via pathways that different to those associated with its effects on T cells.
Q50848721	Induction Immunosuppressive Therapy With Everolimus and Low-Dose Tacrolimus Extended-Release Preserves Good Renal Function at 1 Year After Kidney Transplantation.
Q37577538	Induction of cardiac allograft tolerance across a full MHC barrier in miniature swine by donor kidney cotransplantation
Q42636133	Induction of chronic renal allograft dysfunction in a rat model with complete and exclusive MHC incompatibility
Q34181871	Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure.
Q36824123	Inflammation in the setting of chronic allograft dysfunction post-kidney transplant: phenotype and genotype
Q36204502	Influence of Deceased Donor and Pretransplant Recipient Parameters on Early Overall Kidney Graft-Survival in Germany
Q53603593	Influence of de novo donor-specific antibody on early renal allograft function recovery.
Q44008016	Influence of dialysis duration on the outcome of living kidney transplantation
Q60458975	Influence of recipient and donor IL-10, TNFA and INFG genotypes on the incidence of acute renal allograft rejection
Q42943601	Insertion/Deletion polymorphism of Angiotensin-converting enzyme as a risk factor for chronic allograft nephropathy
Q33736432	Integrative analysis of -omics data and histologic scoring in renal disease and transplantation: renal histogenomics
Q92050362	Interleukin 8 Is Overexpressed in Acute Rejection in Kidney Transplant Patients
Q48682185	Interleukin-2 receptor antagonist does not decrease biopsy-proven acute rejection among adult Chinese kidney transplant recipients
Q45891545	Interstitial fibrosis and tubular atrophy on protocol biopsies at 1 year after renal transplantation
Q40456075	Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies.
Q85103454	Intragraft Toll-like receptor profiling in acute renal allograft rejection
Q57816696	Intrarenal Complement System Transcripts in Chronic Antibody-Mediated Rejection and Recurrent IgA Nephropathy in Kidney Transplantation
Q35332030	Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection
Q93063054	Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical Practice
Q38806679	Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?
Q48160896	Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.
Q44105983	Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival
Q35550570	Isolated endarteritis and kidney transplant survival: a multicenter collaborative study
Q50069790	Isolated v-lesion in kidney transplant recipients: Characteristics, association with DSA, and histological follow-up.
Q27023312	Issues in solid-organ transplantation in children: translational research from bench to bedside.
Q91989861	K121Q polymorphism in the Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 gene is associated with acute kidney rejection
Q50993047	Kidney Transplant With Low Levels of DSA or Low Positive B-Flow Crossmatch: An Underappreciated Option for Highly Sensitized Transplant Candidates.
Q47786299	Kidney allograft failure in the steroid-free immunosuppression era: A matched case-control study.
Q51080659	Kidney allograft function and histology in recipients dying with a functioning graft.
Q46211382	Kidney allograft survival after acute rejection, the value of follow-up biopsies
Q48473530	Kidney graft outcome and quality (after transplantation) from uncontrolled deceased donors after cardiac arrest
Q35177040	Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy
Q35099941	Kidney injury molecule-1 expression is closely associated with renal allograft damage
Q46322442	Kidney intragraft donor-specific antibodies as determinant of antibody-mediated lesions and poor graft outcome
Q37552423	Kidney paired donation in the presence of donor-specific antibodies
Q48690320	Kidney transplantation from pediatric donors in a single Chinese center
Q33873191	Kidney transplantation in a low-resource setting: Nigeria experience
Q38658621	Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair.
Q37591422	Kidney transplantation: analysis of the expression and T cell-mediated activation of latent TGF-β.
Q96304732	Klotho as a potential predictor of deceased donor kidney transplantation outcomes
Q50037308	Late Conversion to Belatacept After Kidney Transplantation: Outcome and Prognostic Factors.
Q27006030	Late and chronic antibody-mediated rejection: main barrier to long term graft survival
Q93121340	Late impact of preformed anti-HLA antibodies on kidney graft outcome
Q41834576	Late kidney dysfunction in a kidney transplant recipient
Q38064945	Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation
Q53193485	Light-microscopic characteristics of IgG4-related tubulointerstitial nephritis: distinction from non-IgG4-related tubulointerstitial nephritis.
Q51413561	Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy.
Q53782591	Living-donor kidney transplantation with existing anti-donor specific antibodies at a Japanese single center.
Q64902285	Long-term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology.
Q36765021	Long-term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation
Q91301304	Long-term Trends in the Clinicopathologic Features of Kidney Transplant Recipients With Graft Dysfunction
Q43499998	Long-term clinicopathological impact of calcineurin inhibitor cessation without specific cytoreductive induction in kidney transplantation
Q43064220	Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis
Q38670363	Long-term outcomes of simultaneous heart and kidney transplantation in pediatric recipients.
Q51362715	Long-term pancreatic allograft survival after renal retransplantation in prior simultaneous pancreas-kidney recipients.
Q35948016	Loss of CD28 on Peripheral T Cells Decreases the Risk for Early Acute Rejection after Kidney Transplantation
Q87465635	Low serum mannose-binding lectin levels are associated with inflammation and apoptosis in early surveillance allograft biopsies
Q26785848	Lymphatic disorders after renal transplantation: new insights for an old complication
Q82978410	Lymphocyte ATP immune cell function assay in pediatric renal transplants: is it useful?
Q36186406	Lymphocyte Activation Markers in Pediatric Kidney Transplant Recipients
Q35781773	Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction
Q48162719	Lymphoid-Like Structures with Distinct B Cell Areas in Kidney Allografts are not Predictive for Graft Rejection. A Non-human Primate Study.
Q34828532	M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN.
Q53894725	Macrophages and T lymphocytes are the predominant cells in intimal arteritis of resected renal allografts undergoing acute rejection.
Q43700035	Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival.
Q37352506	Many de novo donor-specific antibodies recognize β2 -microglobulin-free, but not intact HLA heterodimers
Q36417863	Markers of Endothelial-to-Mesenchymal Transition: Evidence for Antibody-Endothelium Interaction during Antibody-Mediated Rejection in Kidney Recipients
Q49916971	Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection
Q35605144	Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection
Q37424651	Mechanism of cellular rejection in transplantation
Q85194475	Medullary ray injury in renal allografts
Q50550776	Mesenchymal stem cells infusion prevents acute cellular rejection in rat kidney transplantation.
Q87252726	Methods of analysis for peritubular capillaritis and glomerulitis in acute renal rejection: capillaritis in management of routine diagnosis
Q42017986	MicroRNA and Renal Allograft Monitoring
Q37146807	MicroRNA expression profiles predictive of human renal allograft status
Q34203975	MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA.
Q50085439	MicroRNA-709 Mediates Acute Tubular Injury through Effects on Mitochondrial Function.
Q45898843	Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM).
Q44260404	Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies.
Q60194443	Microvascular inflammation in renal allograft biopsies assessed by endothelial and leukocyte co‐immunostain: a retrospective study on reproducibility and clinical/prognostic correlates
Q35639150	Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?
Q37573081	Mining the human urine proteome for monitoring renal transplant injury
Q57202180	Modulation of Innate Immune Cells to Create Transplant Tolerance
Q35629098	Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling.
Q39466553	Molecular diagnosis of antibody-mediated rejection in human kidney transplants
Q40734481	Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes
Q38089948	Molecular monitoring for rejection and graft outcome in kidney transplantation
Q38247310	Molecular monitoring of alloimmune-mediated injury in kidney transplant patients
Q34005059	Molecular pathogenesis of post-transplant acute kidney injury: assessment of whole-genome mRNA and miRNA profiles
Q37724869	Molecular pathways involved in loss of graft function in kidney transplant recipients.
Q33562254	Molecular phenotypes of acute rejection predict kidney graft prognosis
Q37892320	Molecular phenotypes of kidney graft rejection
Q37327986	Molecular profiling of acute and chronic rejections of renal allografts
Q35985731	Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients
Q44445010	Mononuclear inflammatory infiltrate and microcirculation injury in acute rejection: role in renal allograft survival
Q41613327	Moon phases and moon signs do not influence morbidity, mortality and long-term survival, after living donor kidney transplantation
Q46335702	Morphologic Features and Clinical Impact of Arteritis Concurrent with Transplant Glomerulopathy
Q37648959	Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.
Q89425929	Mycophenolic acid concentrations in peripheral blood mononuclear cells are associated with the incidence of rejection in renal transplant recipients
Q40131984	NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation.
Q37822153	Nasopharyngeal T-cell monomorphic posttransplant lymphoproliferative disorders and combined IgA nephropathy and membranous glomerulonephritis in a patient with renal transplantation: a case report with literature review
Q58024471	Nephrosclerosis and carotid atherosclerosis: Lessons from kidney donor histology
Q38854254	Nephrotoxicity in children with frequently relapsing nephrotic syndrome receiving long-term cyclosporine treatment
Q33891669	Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model.
Q85476227	Neutrophil gelatinase-associated lipocalin is a sensitive biomarker for the early diagnosis of acute rejection after living-donor kidney transplantation
Q90175984	No Major Effect of Innate Immune Genetics on Acute Kidney Rejection in the First 2 Weeks Post-Transplantation
Q47577521	Non-invasive evaluation of stable renal allograft function using point shear-wave elastography
Q33434515	Non-invasive imaging of acute renal allograft rejection in rats using small animal F-FDG-PET.
Q55311028	Non-invasive messenger RNA transcriptional evaluation in human kidney allograft dysfunction.
Q88944201	Non-invasive staging of chronic kidney allograft damage using urine metabolomic profiling
Q95424038	Noninvasive analyses of kidney injury molecule-1 messenger RNA in kidney transplant recipients with graft dysfunction
Q91974913	Noninvasive assessment of renal fibrosis by magnetic resonance imaging and ultrasound techniques
Q37637948	Noninvasive diagnosis of acute rejection of renal allografts
Q47100818	Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney Transplant
Q58727204	Novel urinary exosomal biomarkers of acute T cell-mediated rejection in kidney transplant recipients: A cross-sectional study
Q35565364	One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts
Q41873223	Opportunistic infections in a renal transplant recipient
Q35210278	Optimal cutoff point for immunoperoxidase detection of C4d in the renal allograft: results from a multicenter study
Q37621867	Optimization for peptide sample preparation for urine peptidomics
Q38966321	Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and Platform.
Q37305589	Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii
Q35885244	Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
Q84104638	Outcome of combined liver and kidney transplantation in hepatitis C: a single-center long-term follow-up experience
Q53861449	Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy.
Q52656859	Outcome of renal transplantation in small infants: a match-controlled analysis.
Q36334708	Outcomes for primary kidney transplantation from donation after Citizens' death in China: a single center experience of 367 cases
Q46185349	Outcomes of Highly Sensitized Patients Undergoing Simultaneous Liver and Kidney Transplantation: A Single-Center Experience With Desensitization
Q42247863	Outcomes of combination therapy for chronic antibody-mediated rejection in renal transplantation
Q48603371	Outcomes of simultaneous pancreas-kidney transplantation from brain-dead and controlled circulatory death donors.
Q34699278	Pancreas transplantation: The Wake Forest experience in the new millennium
Q35128345	Pancreas transplantation: lessons learned from a decade of experience at Wake Forest Baptist Medical Center
Q33398429	Pathologic characteristics of transplanted kidney xenografts
Q33522450	Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study
Q36529421	Pathological diagnosis of antibody-mediated rejection in renal allograft without c4d staining, how much reliable?
Q57151742	Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
Q83700004	Pathology: donor biopsy evaluation at time of renal grafting
Q38102662	Pathophysiology and treatment options of chronic renal allograft damage
Q37531788	Patterns of Early Rejection in Renal Retransplantation: A Single-Center Experience.
Q41782407	Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatment.
Q42133384	Percutaneous native renal biopsy adequacy: a successful interdepartmental quality improvement activity
Q88177136	Peripheral Blood Regulatory T Cells Are Diminished in Kidney Transplant Patients With Chronic Allograft Nephropathy
Q44608227	Peritubular capillaritis in early renal allograft dysfunction is an indicator of acute rejection
Q84484568	Peritubular capillary basement membrane changes in chronic renal allograft rejection: Comparison of light microscopic and ultrastructural observations
Q34930059	Perturbations in the urinary exosome in transplant rejection
Q37282196	Pharmacological Tie2 activation in kidney transplantation
Q38005448	Phenotypes of antibody-mediated rejection in organ transplants
Q34423734	Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation
Q55216175	Pilot Analysis of Late Conversion to Belatacept in Kidney Transplant Recipients for Biopsy-Proven Chronic Tacrolimus Toxicity.
Q40560362	Pilot Randomized Trial of Tacrolimus/Everolimus vs Tacrolimus/Enteric-Coated Mycophenolate Sodium in Adult, Primary Kidney Transplant Recipients at a Single Center
Q38620851	Plasma Cell-Rich Rejection After Kidney Transplantation and the Role of Donor-Specific Antibodies: A Case Report and Review of the Literature
Q36283539	Plasma cell-rich acute rejection of the renal allograft: A distinctive morphologic form of acute rejection?
Q47396023	Plasma cell-rich acute rejections in living-related kidney transplantation: a clinicopathological study of 50 cases
Q42439336	Plasma exchange and intravenous immunoglobulin in the treatment of antibody-mediated rejection after kidney transplantation: a single-center historic cohort study
Q48271416	Plasma-cell-rich infiltrates in paediatric renal transplant biopsies are associated with increased risk of renal allograft failure
Q33394870	Plasmapheresis therapy in renal transplant patients: five-year experience.
Q88200625	Platelet factor 4 protects kidney allograft in a rat kidney transplantation model
Q35228522	Platelets in early antibody-mediated rejection of renal transplants
Q38662974	Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.
Q38668319	Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients
Q48365333	Polymorphisms of nucleotide factor of activated T cells cytoplasmic 2 and 4 and the risk of acute rejection following kidney transplantation.
Q53591741	Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year.
Q86779666	Post-transplant soluble CD30 levels are associated with early subclinical rejection in kidney transplantation
Q40159121	Postanastomotic transplant renal artery stenosis: association with de novo class II donor-specific antibodies.
Q38645385	Potential Roles for C1 Inhibitor in Transplantation
Q47835422	Potential association between elevated serum human epididymis protein 4 and renal fibrosis: A systemic review and meta-analysis.
Q42279035	Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study
Q42905393	Potential of Noninvasive Serial Assessment of Acute Renal Allograft Rejection by 18F-FDG PET to Monitor Treatment Efficiency
Q39585890	Pre-existing arteriosclerotic intimal thickening in living-donor kidneys reflects allograft function
Q41175813	Pre-implantation analysis of kidney biopsies from expanded criteria donors: testing the accuracy of frozen section technique and the adequacy of their assessment by on-call pathologists.
Q50022460	Pre-transplant AT1R antibodies correlate with early allograft rejection.
Q36822786	Pre-transplant Evaluation of Donor Urinary Biomarkers can Predict Reduced Graft Function After Deceased Donor Kidney Transplantation
Q31056244	Predicting Individual Renal Allograft Outcomes Using Risk Models with 1-Year Surveillance Biopsy and Alloantibody Data.
Q53085854	Prediction of Renal Allograft Acute Rejection Using a Novel Non-Invasive Model Based on Acoustic Radiation Force Impulse.
Q92469050	Prediction of renal allograft chronic rejection using a model based on contrast-enhanced ultrasonography
Q34534855	Predominance of intraglomerular T-bet or GATA3 may determine mechanism of transplant rejection
Q53120860	Preemptive therapy versus valgancyclovir prophylaxis in cytomegalovirus-positive kidney transplant recipients receiving antithymocyte globulin induction.
Q34124202	Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation
Q64899061	Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation.
Q40959934	Preimplantation Kidney Biopsies of Extended Criteria Donors Have a Heavier Inflammatory Burden Than Kidneys From Standard Criteria Donors
Q92544364	Preoperative Comorbidities and Outcomes of Medically Complex Living Kidney Donors
Q40217900	Presence of arteriolar hyalinosis in post-reperfusion biopsies represents an additional risk to ischaemic injury in renal transplant
Q43779103	Pretransplant risk stratification for early survival of renal allograft recipients.
Q43817587	Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss
Q92547569	Pretransplant transcriptomic signature in peripheral blood predicts early acute rejection
Q37723175	Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program
Q47680604	Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation model
Q38016076	Primer on renal transplantation
Q34084853	Probabilistic (Bayesian) modeling of gene expression in transplant glomerulopathy
Q45784756	Probability of deceased donor kidney transplantation based on % PRA.
Q64965724	Procurement Biopsy Findings Versus Kidney Donor Risk Index for Predicting Renal Allograft Survival.
Q44149269	Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer
Q40626336	Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients
Q47102162	Progression of Interstitial Fibrosis during the First Year after Deceased Donor Kidney Transplantation among Patients with and without Delayed Graft Function
Q39712114	Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes
Q54211464	Prospective Assessment of Adenovirus Infection in Pediatric Kidney Transplant Recipients.
Q35730607	Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients
Q40997354	Proteinuria 1 year after renal transplantation is associated with impaired graft survival in children
Q33550893	Proteomic profiling of renal allograft rejection in serum using magnetic bead-based sample fractionation and MALDI-TOF MS.
Q33587191	Proteomic signatures in plasma during early acute renal allograft rejection
Q89450524	Protocol biopsies in pediatric renal transplantation: a precious tool for clinical management
Q84409727	Protocol biopsy of a transplanted kidney as a tool for monitoring adequacy of immunosuppressive therapy: 10 years of experience from a single transplant center
Q38416197	Pyruvate Kinase M2: A Novel Biomarker for the Early Detection of Acute Kidney Injury
Q50198363	Quantification of Interstitial Fibrosis in Renal Allografts and Clinical Correlates of Long-Term Graft Function.
Q46790238	Quantitative analyses of kidney injury molecule-1 messenger RNA in kidney transplant recipients with graft dysfunction.
Q93203336	Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus
Q40188939	Randomized Controlled Trial of Mineralocorticoid Receptor Blockade in Children with Chronic Kidney Allograft Nephropathy
Q40435609	Randomized trial of rATg/Daclizumab vs. rATg/Alemtuzumab as dual induction therapy in renal transplantation: Results at 8years of follow-up.
Q93063069	Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids
Q53236659	Rapid Resolution of Donor-Derived Glomerular Fibrin Thrombi After Deceased Donor Kidney Transplantation.
Q85949252	Rat renal transplant model for mixed acute humoral and cellular rejection: Weak correlation of serum cytokines/chemokines with intragraft changes
Q47811161	Re-evaluation of glomerulitis using occlusion criteria based on the Banff 2013 revision: a retrospective study
Q45057936	Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study.
Q87014958	Reappraisal of PLA2R1 in membranous nephropathy: immunostaining method influence and association with IgG4-dominant phenotype
Q33408239	Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome
Q36314959	Reassessing the Significance of Intimal Arteritis in Kidney Transplant Biopsy Specimens
Q37301840	Recent developments in kidney transplantation--a critical assessment
Q34659840	Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons.
Q88640855	Recurrent IgA Nephropathy After Kidney Transplantation
Q48117755	Recurrent lupus nephritis after transplantation: Clinicopathological evaluation with protocol biopsies
Q50941759	Refinement of the criteria for ultrastructural peritubular capillary basement membrane multilayering in the diagnosis of chronic active/acute antibody-mediated rejection.
Q40199898	Regional differences in the management and outcome of kidney transplantation in patients with human immunodeficiency virus infection: A 3-year retrospective cohort study.
Q36242244	Regulation of MUTYH, a DNA Repair Enzyme, in Renal Proximal Tubular Epithelial Cells
Q33804736	Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates
Q46132415	Relation of urinary gene expression of epithelial-mesenchymal transition markers with initial events and 1-year kidney graft function
Q38544617	Relationship among C1q-fixing de novo donor specific antibodies, C4d deposition and renal outcome in transplant glomerulopathy.
Q41160324	Relationships among injury, fibrosis, and time in human kidney transplants.
Q53103451	Renal Allograft Histology at 10 Years After Transplantation in the Tacrolimus Era: Evidence of Pervasive Chronic Injury.
Q50993283	Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells.
Q52845695	Renal Association Clinical Practice Guideline on post-operative care of the kidney transplant recipient.
Q34746617	Renal and urinary levels of endothelial protein C receptor correlate with acute renal allograft rejection
Q33407913	Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy
Q42343473	Renal association clinical practice guideline in post-operative care in the kidney transplant recipient
Q43224194	Renal function outcomes in kidney transplant recipients after conversion to everolimus-based immunosuppression regimen with CNI reduction or elimination
Q37459131	Renal histologic parameters influencing postoperative renal function in renal cell carcinoma patients.
Q33396969	Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Q43629855	Renal transplant elasticity ultrasound imaging: correlation between normalized strain and renal cortical fibrosis
Q38967258	Renal transplant immunology in the last 20 years: A revolution towards graft and patient survival improvement
Q34412887	Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.
Q58798093	Rethinking immune hepatitis, an old concept for liver allograft rejection: Relevance of glutathione S-transferase T1 mismatch
Q53671421	Retrospective evaluation of the effect of mycophenolate mofetil dosage on survival of kidney grafts based on biopsy results.
Q36619363	Review of the early diagnoses and assessment of rejection in vascularized composite allotransplantation
Q38772536	Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation
Q35250310	Revisiting traditional risk factors for rejection and graft loss after kidney transplantation
Q40417600	Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients.
Q84694035	Risk Factors for Banff Borderline Acute Rejection in Protocol Biopsies and Effect on Renal Graft Function
Q37662995	Risk factors and outcomes of delayed graft function in renal transplant recipients receiving a steroid sparing immunosuppression protocol
Q48655730	Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipients
Q41527816	Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety.
Q37989298	Rituximab in immunologic glomerular diseases
Q82861887	Rituximab in the treatment of acute cellular rejection of renal allograft with CD20-positive clusters in the infiltrate
Q37241071	Rituximab in the treatment of refractory late acute antibody-mediated rejection: Our initial experience
Q55378686	Role of Anti-MICA Antibodies in Graft Survival of Renal Transplant Recipients of India.
Q42372583	STAT4 gene polymorphism in patients after renal allograft transplantation
Q26799916	Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients
Q40586736	Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients
Q48511018	Safety and Efficacy of Induction Therapy With Thymoglobulin in AB0-Incompatible Kidney Transplantation
Q92469286	Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial
Q39116608	Sensitization, pathologic, and imaging findings comparing symptomatic and quiescent failed renal allografts
Q51043732	Sequential analysis of donor-specific antibodies and pathological findings in acute antibody-mediated rejection in a rat renal transplantation model.
Q53378331	Serum MicroRNA-99a Helps Detect Acute Rejection in Renal Transplantation.
Q85570105	Serum level of soluble fibrinogen-like protein 2 in renal allograft recipients with acute rejection: a preliminary study
Q57489236	Severe Phlebitis Accompanying Vascular Rejection Type Acute T Cell-Mediated Rejection in Renal Transplantation
Q41494974	Should We Always Defer Treatment of Kidney Disease When There Is Extensive Interstitial Fibrosis on Biopsy?
Q28486264	Significance and suppression of redundant IL17 responses in acute allograft rejection by bioinformatics based drug repositioning of fenofibrate
Q39242737	Significance of Time-Zero Biopsy for Graft Renal Function After Deceased Donor Kidney Transplantation.
Q64264323	Significance of the Pathologic Findings in Implantation Biopsies for Kidney Allografts Survival
Q36028239	Simultaneous pancreas and kidney (SPK) retransplantation in prior SPK recipients
Q40644345	Single-Dose Basiliximab Induction in Low-Risk Renal Transplant Recipients
Q50955240	Soluble BAFF Cytokine Levels and Antibody-Mediated Rejection of the Kidney Allograft.
Q43466537	Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft
Q91028577	Sox7 is involved in antibody-dependent endothelial cell activation and renal allograft injury via the Jagged1-Notch1 pathway
Q33873655	Spatial differences in the presence of FOXP3+ and GranzymeB+ T cells between the intra- and extravascular compartments in renal allograft vasculopathy
Q43898088	Specificity and sensitivity of screening for anti-HLA antibodies in kidney allograft dysfunction.
Q39393606	Study of CC chemokine receptor 5 in renal allograft rejection
Q35790552	Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts
Q36281955	Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation
Q88688862	Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation
Q34455315	Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation
Q51180951	Successful Rescue of Late-onset Antibody-mediated Rejection 12 Years After Living-donor Intestinal Transplantation: A Case Report.
Q89777486	Successful desensitization with proteasome inhibition and costimulation blockade in sensitized nonhuman primates
Q40321824	Successful rescue of refractory acute antibody-mediated renal allograft rejection with splenectomy--a case report
Q51012535	Supplementation with a new therapeutic oxygen carrier reduces chronic fibrosis and organ dysfunction in kidney static preservation.
Q38866277	Surveillance biopsies after paediatric kidney transplantation: A review
Q35669313	Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection
Q35977167	Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant
Q46019531	T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function.
Q47120971	T-Cell Composition of the Lymph Node Is Associated with the Risk for Early Rejection after Renal Transplantation.
Q53143416	TIPE2, a novel biomarker for clinical chronic kidney allograft rejection.
Q33694700	Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft Rejection
Q44709602	Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial
Q44222425	Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation
Q42276202	Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients
Q37361121	The Association Between Viral Infections and Co-stimulatory Gene Polymorphisms in Kidney Transplant Outcomes
Q42174325	The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.
Q48112113	The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.
Q47246603	The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations.
Q38067050	The Banff classification revisited
Q47834729	The Effects of Brain Death and Ischemia on Tolerance Induction are Organ-Specific.
Q53588322	The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Q93052080	The Interferon-Gamma +874 A/T Polymorphism Is Not Associated With CMV Infection After Kidney Transplantation
Q37410772	The Oxidative and Inflammatory State in Patients with Acute Renal Graft Dysfunction Treated with Tacrolimus.
Q38676925	The Revised (2013) Banff Classification for Antibody-Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations
Q51010023	The Value of Protocol Biopsies to Identify Patients With De Novo Donor-Specific Antibody at High Risk for Allograft Loss.
Q34457205	The anti-fibrotic effect of mycophenolic acid-induced neutral endopeptidase.
Q81562856	The art of classifying renal allograft pathology
Q37359074	The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy
Q37704938	The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients.
Q47340562	The effect of desensitization therapy in kidney transplantation
Q83629646	The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients
Q53607269	The efficacy and safety of intensified enteric-coated mycophenolate sodium with low exposure of calcineurin inhibitors in Chinese de novo kidney transplant recipients: a prospective study.
Q33884782	The evolution of the Banff classification schema for diagnosing renal allograft rejection and its implications for clinicians
Q41926369	The identification of novel potential injury mechanisms and candidate biomarkers in renal allograft rejection by quantitative proteomics
Q84647484	The impact of C4d staining as a humoral injury marker
Q43928123	The impact of ICAM1 and VCAM1 gene polymorphisms on chronic allograft nephropathy and transplanted kidney function
Q38003049	The impact of donor-specific anti-HLA antibodies on late kidney allograft failure
Q35865046	The impact of pretransplant donor-specific antibodies on graft outcome in renal transplantation: a six-year follow-up study
Q45435047	The impact of time-zero biopsy on early graft outcomes after living donor kidney transplantation.
Q37201483	The innate immune system and transplantation
Q37563986	The pathogenesis and treatment of chronic allograft nephropathy
Q37813404	The pathology of chronic allograft dysfunction
Q51323037	The potential role of perivascular lymphatic vessels in preservation of kidney allograft function.
Q41828910	The predictive value of kidney allograft baseline biopsies for long-term graft survival
Q41150961	The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation
Q43241187	The prevalence of C4d-positive renal allografts in 134 consecutive biopsies in Thai patients
Q54116671	The prognostic values of caveolin-1 immunoreactivity in peritubular capillaries in patients with kidney transplantation.
Q50734459	The regulatory T cell effector soluble fibrinogen-like protein 2 induces tubular epithelial cell apoptosis in renal transplantation.
Q64086710	The relation between zero-time pretransplant deceased donor renal biopsy and kidney transplant survival
Q38062343	The renal biopsy in the genomic era.
Q54524837	The reproducibility and predictive value on outcome of renal biopsies from expanded criteria donors.
Q38048605	The role of complement in antibody-mediated rejection in kidney transplantation
Q38013049	The role of complement in the early immune response to transplantation.
Q50458666	The role of macrophages in the development of human renal allograft fibrosis in the first year after transplantation.
Q53579926	The role of renin-angiotensin system in the chronic allograft nephropathy: an immunohistochemical study.
Q35975914	The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation
Q38247690	The significance of histological diagnosis in renal allograft biopsies in 2014.
Q84522326	The significance of renal C4d staining in patients with BK viruria, viremia, and nephropathy
Q38151921	The specificity of acute and chronic microvascular alterations in renal allografts
Q30411597	The urine microRNA profile may help monitor post-transplant renal graft function
Q37690953	The yin and yang of B cells in graft rejection and tolerance
Q94500761	Therapeutic Effects and Functional Mechanism of Intravenous Immunoglobulin in Preclinical Rat Renal Transplant Model of Antibody-Mediated Rejection
Q38118112	Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013.
Q40745610	Therapy Modalities for Antibody Mediated Rejection in Renal Transplant Patients
Q43507137	Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patients
Q44522008	Three-yr safety and efficacy of everolimus and low-dose cyclosporine in de novo pediatric kidney transplant patients.
Q40856216	Thrombin may modulate dendritic cell activation in kidney transplant recipients with delayed graft function.
Q33392412	Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies
Q44535101	Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure
Q39242744	Tissue Expression of Aquaporin 2 Is Correlated to Urine Output and Allograft Function in Sensitized Kidney Transplant Patients
Q42613345	Top Differential Diagnosis Should Be Microscopic Polyangiitis in ANCA-Positive Patient with Diffuse Pulmonary Hemorrhage and Hemosiderosis
Q53117621	Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant.
Q37573199	Transcriptional Perturbations in Graft Rejection
Q53039951	Transcriptional profiling of belatacept and calcineurin inhibitor therapy in renal allograft recipients.
Q61805676	Transient increase of activated regulatory T cells early after kidney transplantation
Q38436456	Translational implications of endothelial cell dysfunction in association with chronic allograft rejection.
Q83401631	Transplant glomerulopathy: clinical and pathological correlations
Q38205229	Transplant glomerulopathy: the interaction of HLA antibodies and endothelium
Q91819183	Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study
Q39406891	Transplant trials with Tregs: perils and promises
Q52145906	Transplantation of kidneys from uncontrolled donation after circulatory determination of death: comparison with brain death donors with or without extended criteria and impact of normothermic regional perfusion.
Q34495912	Transplanting the elderly: Balancing aging with histocompatibility.
Q42102593	Treatment of Antibody-Mediated Rejection After Kidney Transplantation - 10 Years' Experience With Apheresis at a Single Center.
Q65000602	Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection.
Q51350894	Tubular and endothelial chimerism in renal allografts using fluorescence and chromogenic in situ hybridization (FISH, CISH) technology.
Q39413604	Tubular epithelial syndecan-1 maintains renal function in murine ischemia/reperfusion and human transplantation
Q38824702	Tubulointerstitial nephritis and Fanconi syndrome in a patient with primary Sjögren's syndrome accompanied by antimitochondrial antibodies: A case report and review of the literature
Q37426941	Tubulointerstitial nephritis with uveitis in Chinese adults
Q86881970	Ultrasonography parameters and histopathology findings in transplanted kidney
Q87538818	Ultrasound strain zero-crossing elasticity measurement in assessment of renal allograft cortical hardness: a preliminary observation
Q47196348	Uncontrolled donation after circulatory death: comparison of two kidney preservation protocols on graft outcomes.
Q42281859	Upregulation of microRNA 142-3p in the peripheral blood and urinary cells of kidney transplant recipients with post-transplant graft dysfunction
Q40445539	Ureteral stent placement and immediate graft function are associated with increased risk of BK viremia in the first year after kidney transplantation.
Q36223302	Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection
Q51169417	Urinary Metabolomics for Noninvasive Detection of Antibody-Mediated Rejection in Children After Kidney Transplantation.
Q57014271	Urinary Metabolomics for Noninvasive Detection of Borderline and Acute T Cell-Mediated Rejection in Children After Kidney Transplantation
Q50882107	Urinary Type III Procollagen Is Associated With Chronic Allograft Dysfunction and Predicts Graft Survival.
Q54978699	Urinary Virome Perturbations in Kidney Transplantation.
Q33814925	Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction
Q47561986	Urinary exosomal viral microRNA as a marker of BK virus nephropathy in kidney transplant recipients.
Q48220293	Urinary mRNA for the Diagnosis of Renal Allograft Rejection: The Issue of Normalization
Q38769922	Use of polyclonal/monoclonal antibody therapies in transplantation
Q82955043	Usefulness of 3-month protocol biopsy of kidney allograft to detect subclinical rejection under triple immunosuppression with basiliximab: a single center experience
Q93196002	Usefulness of morphometric image analysis with Sirius Red to assess interstitial fibrosis after renal transplantation from uncontrolled circulatory death donors
Q50743724	Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated Rejection.
Q46351473	Utility of Shear Wave Elastography for Assessing Allograft Fibrosis in Renal Transplant Recipients: A Pilot Study.
Q58574465	Validation Study of an Operational Tolerance Signature in Korean Kidney Transplant Recipients
Q84039211	Validation of the Oxford classification of IgA nephropathy
Q100505828	Validity and utility of urinary CXCL10/Cr immune monitoring in pediatric kidney transplant recipients
Q40634986	Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss
Q55021686	Vascular Endothelial Growth Factor Gene Polymorphism Is Associated With Long-term Kidney Allograft Outcomes.
Q43982164	Vienna experience of ABO-incompatible living-donor kidney transplantation
Q26796641	What is the best way to measure renal fibrosis?: A pathologist’s perspective
Q43037503	Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: endovenous or arterial?
Q40451934	[Care of the adult kidney transplant recipient].
Q83425876	[Kidney transplant pathology]
Q84215841	[New faces of acute rejection in 2008]
Q82564747	[Role of anti-HLA antibodies whether or not they are directed against the donor during chronic renal graft dysfunction]
Q53624421	[The epithelial-mesenchymal transition and fibrosis of the renal transplant].
Q82093915	[The role of endothelial cells in allograft rejection]
Q36914549	miRNA profiling discriminates types of rejection and injury in human renal allografts

P356	DOI	10.1111/J.1600-6143.2008.02159.X
P698	PubMed publication ID	18294345
P5875	ResearchGate publication ID	5558601

P50	author	Cinthia B Drachenberg	Q88971263
		John C Papadimitriou	Q104508802
		Philip F Halloran	Q40000948
P2093	author name string	I Roberts
		M Valente
		M Haas
		R B Mannon
		R B Colvin
		P Randhawa
		S S Iskandar
		M Mengel
		K Solez
		L C Racusen
		B Sis
		D Glotz
		E Kraus
		R N Smith
		A B Fogo
		G Banfi
		G Einecke
		D S R David
		H Regele
		K Renaudin
		W Baldwin
		E Lerut
		I W Gibson
		D Seron
		M Mihatsch
		B J Nankivell
		V Nickeleit
		A B Collins
		F Cosio
P2860	cites work	Organ donation: the gift, the weight and the tyranny of good acts	Q47297701
		Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection	Q47869308
		Changes in the transcriptome in allograft rejection: IFN-gamma-induced transcripts in mouse kidney allografts.	Q51941984
		Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients.	Q53003709
		International variation in histologic grading is large, and persistent feedback does not improve reproducibility.	Q53301318
		Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets.	Q53521493
		Early loss of renal transcripts in kidney allografts: relationship to the development of histologic lesions and alloimmune effector mechanisms.	Q53557584
		Focal peritubular capillary C4d deposition in acute rejection.	Q53641782
		Incidence of C4d Stain in Protocol Biopsies from Renal Allografts: Results from a Multicenter Trial	Q58378349
		The Banff 97 working classification of renal allograft pathology	Q59314413
		Tubulitis and epithelial cell alterations in mouse kidney transplant rejection are independent of CD103, perforin or granzymes A/B.	Q33251846
		Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection	Q35666593
		Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology?	Q35711160
		Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection	Q36017741
		The significance of subclinical rejection and the value of protocol biopsies	Q36517003
		Protocol biopsies in renal transplantation: prognostic value of structural monitoring	Q36863467
		C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques	Q40260954
		Outcome of kidney transplantation from high-risk donors is determined by both structure and function	Q40814565
		Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause	Q43580802
		The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy	Q44378940
		Lesions of T-cell-mediated kidney allograft rejection in mice do not require perforin or granzymes A and B.	Q44844473
		Risk factors for capillary C4d deposition in kidney allografts: evaluation of a large study cohort	Q45022068
P433	issue	4
P407	language of work or name	English	Q1860
P921	main subject	pathology	Q7208
P304	page(s)	753-760
P577	publication date	2008-02-19
P1433	published in	American Journal of Transplantation	Q4744273
P1476	title	Banff 07 classification of renal allograft pathology: updates and future directions
P478	volume	8

Banff 07 classification of renal allograft pathology: updates and future directions

scientific article

Reverse relations